A mom went into anaphylactic shock from the contrast dye used in her CT scan, causing her to die within 90 minutes of its ...

U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four ...

The trial's education package focuses on the subjects’ understanding and adherence to the use of intranasal steroid sprays.

PINE BELT, Miss. (WDAM) - Spring is here and it’s an exciting time for some. But not so exciting for those with allergies. Forrest General Hospital Dr. Hannah Ramsey said doctors are starting to see ...

ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...

Good day, and welcome to ARS Pharmaceuticals fourth quarter and full year 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded. I would now like ...

Today is the first day of Spring, which means allergy season is creeping into Washington. A new study by the Allergy and ...

A migraine attack is more than a headache. It can derail your entire day.

ARS Pharmaceuticals, Inc.’s SPRY share price has surged by 19.57%, which has investors questioning if this is right time to ...

Habibi’s Mediterranean-branded Hummus Lebanese Style is being recalled. The product may contain peanuts, an undeclared ...

A popular hummus brand sold across parts of Canada is being recalled after a consumer suffered an allergic reaction. The ...

Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...